What is the recommended anticoagulation regimen for a patient with a mechanical heart valve, including target INR, warfarin dosing, and bridging strategies?

Anticoagulation for Mechanical Heart Valves

All patients with mechanical heart valves require lifelong warfarin anticoagulation, with target INR determined by valve position and thromboembolic risk factors. 122

Target INR by Valve Position and Risk

Mechanical Aortic Valve

• Low-risk patients (no AF, no prior thromboembolism, normal LV function, newer-generation valve): Target INR 2.5 (range 2.0-3.0) 12
• High-risk patients (AF, prior thromboembolism, hypercoagulable state, older-generation valve like ball-in-cage, severe LV dysfunction): Target INR 3.0 (range 2.5-3.5) 1

Mechanical Mitral Valve

• Target INR 3.0 (range 2.5-3.5) for all patients 122
• The higher target reflects the substantially elevated thromboembolism risk with mitral position compared to aortic position 1

Double Valve Replacement

• Follow mitral valve recommendations: Target INR 3.0 (range 2.5-3.5) 22

Older-Generation Valves (Caged Ball/Disk)

• Target INR 3.0 (range 2.5-3.5) PLUS aspirin 75-100 mg daily 22

Warfarin Dosing Strategy

Initial Dosing

• Start with 2-5 mg daily (avoid loading doses as they increase bleeding risk without faster therapeutic protection) 22
• Use lower doses (2-3 mg) for:
  • Elderly patients (>70 years) 3
  • Patients with CYP2C9 or VKORC1 genetic variations 2
  • Debilitated patients 2

Maintenance Dosing

• Most patients stabilize at 2-10 mg daily 22
• Adjust based on INR monitoring, not fixed schedules
• Female sex and higher baseline INR predict greater warfarin sensitivity 4

Bridging Anticoagulation

Bridging is NOT routinely recommended for mechanical aortic valves without additional risk factors 15. The evidence shows:

• For mechanical aortic valves: No bridging needed in low-risk patients 1. Bridging increases bleeding complications (24% pericardial effusions vs 8%, 8% reoperation for bleeding vs 0%) without reducing thromboembolism 5

• For mechanical mitral valves or high-risk aortic valves: Bridging anticoagulation during subtherapeutic INR period is reasonable (Class IIa recommendation) 1

When Bridging is Used:

• Start postoperative day 2-4 (mean 3.8 days) after surgery 6
• Options include:
  • Unfractionated heparin IV: 80 U/kg bolus, then 18 U/kg/h infusion targeting aPTT 60-80 seconds 3
  • Low-molecular-weight heparin subcutaneous: Fixed dose protocols (e.g., enoxaparin 40 mg twice daily) appear safe and effective 6
• Continue until INR therapeutic for 2 consecutive days

Aspirin Addition

Add aspirin 75-100 mg daily if additional antiplatelet indication exists (e.g., coronary artery disease, prior thromboembolism despite therapeutic INR) 12. This is a Class IIb recommendation, meaning it may be considered but increases bleeding risk modestly when INR is 2.0-3.5 7.

Do NOT add aspirin if INR target is 3.0-4.5 or higher—bleeding risk becomes excessive 7.

Critical Monitoring Points

• INR >4.0 provides no additional benefit and significantly increases bleeding risk 22
• Monitor INR frequently during initiation (every 1-3 days) until stable, then every 4 weeks when stable
• Time in therapeutic range (TTR) should exceed 65-70% for optimal outcomes 8
• Warfarin may provide more stable anticoagulation than acenocoumarol (76% vs 69% TTR) 8

Common Pitfalls to Avoid

1. Drug interactions: Antibiotics (especially ciprofloxacin), alcohol, and marijuana can dramatically elevate INR 9—consider these when INR unexpectedly rises
2. Delayed intracranial hemorrhage: In anticoagulated patients with head trauma, repeat neuroimaging if new symptoms develop even if initial CT was negative 9
3. Mitral valve patients require lower warfarin doses but have higher INR overshoot rates (18.75% vs 16% for aortic) 4—monitor more closely
4. Patient compliance challenges: Higher INR targets (3.0-4.5) result in only 44.5% time in range vs 74.5% for 2.0-3.5 targets 1

Special Considerations

• Bioprosthetic valves: Warfarin only needed for first 3 months (target INR 2.5, range 2.0-3.0), then aspirin alone if no other indication 12
• TAVI patients: Initial 3-6 months with aspirin 75-100 mg daily ± clopidogrel 75 mg (dual therapy increases bleeding without clear benefit) 1
• Missed doses: Take as soon as remembered same day; never double dose 2